Cannitracinum

克念菌素

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCannitracinum
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsProstatic HyperplasiaSepsisPeritonitis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsProstatic HyperplasiaSepsisPeritonitis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A